NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Global Vascular Closure Devices Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023144
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
全球血管閉塞設備市場預測(2021年∼2026年) Global Vascular Closure Devices Market - Forecasts from 2021 to 2026
出版日期: 2021年07月09日內容資訊: 英文 115 Pages




第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 供應商談判力
    • 買方議價能力
    • 新加入企業的威脅
    • 替代品的威脅
    • 功能的競爭企業間的敵對關係
  • 功能價值鏈分析

第5章 全球血管閉合設備(VCD)市場分析:各存取(點閱)

  • 簡介
  • 股骨
  • 橈骨

第6章 全球血管閉合設備(VCD)市場分析:各類型

  • 簡介
  • 被動式血管閉合設備
  • 主動式血管閉合設備

第7章 全球血管閉合設備(VCD)市場分析:各終端用戶

  • 簡介
  • 醫院及診所
  • 門診病人手術中心

第8章 全球血管閉合設備(VCD)市場分析:各手術

  • 簡介
  • 介入心臟病學
  • 影像下治療/血管手術

第9章 全球血管閉合設備(VCD)市場分析:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 其他
  • 中東及非洲
    • 以色列
    • 沙烏地阿拉伯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第10章 競爭環境與分析

  • 主要企業策略分析
  • 新興企業和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第11章 企業簡介

  • Medtronic
  • Terumo
  • Abbott
  • Cordis
  • Biomerics
  • Cardiva Medical, Inc.
  • Vasorum Ltd
  • Biotronik GMBH & CO.KG
  • Boston Scientific Corporation
  • TZ Medical, Inc
Product Code: KSI061611748

The global vascular closure devices (VCDs) market is expected to grow at a compound annual growth rate of 6.88% over the forecast period to reach a market size of US$2.744 billion in 2026 from US$1.723 billion in 2019.

A vascular closure device can be defined as a piece of collagen (a stringy protein found in skin, bone, and connective tissue), metallic clasp, or stitch (line) intended to give prompt fixing of the little cut made in a course after an angiogram. Angiography is the imaging of veins that show up on live X-beam pictures or pictures. These aides show irregularities or direct the treatment of infection. Blood vessel access is usually helped out through the femoral corridor, which is a huge course running past the locale of the crotch. Access through this supply route includes an expert specialist penetrating the conduit with a little needle through the skin and embeddings a plastic sheath or cylinder into the vein through the cut site.

Vascular closure devices (VCD) have arisen as a viable option in contrast to customary mechanical pressure for femoral course conclusion and is as a rule broadly utilized in patients going through catheterization utilizing the femoral course. These gadgets can diminish the chance of hemostasis, work with early understanding preparation, lessen patient inconvenience related to delayed bed rest, improve patient fulfillment, decline clinic length of stay (by the early assembly and decrease of intricacies), and conceivably decrease femoral vein confusions. While utilizing these gadgets may increment procedural expenses, clients of these advances say there is a ton of investment needed downstream by accomplishing quicker hemostasis. These advantages incorporate diminished draining difficulties, a decrease in post-procedural nursing care time required, expanded patient throughput, and quicker quiet ambulation. Getting patients moving around more rapidly additionally helps clinics that have same-day percutaneous coronary mediation (PCI) programs. These devices if used properly and responsibly can help in reducing the number of deaths caused by health problems like peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), and more particularly stroke, which according to the CDC, causes more than 795,000 deaths in the US alone, provided the stroke is not a first-time occurrence.

Additionally, considering the vast market opportunity presented by the high demand for vascular closure devices, several new market players have emerged in the field along with the already existing pharma behemoths, leading to new product launches and collaborations between different market players, which is expected to further boost the vascular closure market growth. For instance, in April 2021, Vivasure released the PerQseal+, which aims to provide a more robust solution in reducing the potential for complications and to enhance control and tactile feedback during surgery. The company also announced the enrolment of the first patient in the Frontier V trial, a European multicentre study of the PerQseal+ device, the trial results of which will offer the operators a completely new solution for saving lives, which is expected to further push the vascular closure market growth towards expansion.

Although there are various factors aiding the growth of the vascular closure devices market issues such as those with suture-based closure devices may affect this market growth. Suture-based closure devices are increasingly being adopted by healthcare professionals for percutaneous closure of large-bore arteriotomies. However, suture-based closure devices are cumbersome and are experiencing a downtick, owing to their long learning curve and increased risk of complications, which is expected to hurt the vascular closure device market during the forecast period.

Growth Factors.

  • High adoption of femoral mode for vascular access during the majority of interventional procedures.

Femoral mode is in effect generally received for vascular access during coronary angiography and other interventional systems. As femoral veins are moderately less inclined to fit in correlation with outspread and grant huge size catheters, the fragment will notice striking development. In addition, the advancement of explicit gadgets giving femoral blood vessel access upgrades the fragment extension abilities. Be that as it may, a few difficulties related to femoral access-site, for example, arteriovenous (AV) fistula, pseudoaneurysm, and blood vessel analyzation limit acknowledgment to a specific degree. Accordingly, thinking about by and large factors and high procedural volume, the section is assessed to develop powerfully during the figure timetable. Moreover, specialty-focused solutions are acquiring prominence in the vascular closure devices market. For instance, a leading supplier of specialty medical devices for critical care and surgery Teleflex announced to showcase their MANTA vascular closure device at the 2019 PCR London Valves-a cross-disciplinary course being held in London, U.K. Specialty-focused solutions are helping healthcare providers to improve the health and patient quality of life worldwide. Companies are increasing efforts to develop products that simplify complex procedures and overcome barriers associated with common procedural challenges, expected to further propel market growth.

Impact of COVID - 19.

The emergence of COVID-19 has affected the procedural volume of a few cardiovascular medicines during the underlying time of pandemics. High danger of Covid contamination during such strategies with expanding hospitalizations of COVID-19 patients brought about methodology deferral. Notwithstanding, with standard working conventions and lessening the number of patients in certain nations, the business is relied upon to grandstand proceeded with development. Besides, authoritative joint efforts and government backing to keep offering successful crisis heart care to patients have supported mechanical income development. Albeit the market has encountered moderate effect during a certain period, it will keep on predicting enormous development.

Competitive Insights.

The increasing demand for vascular closure devices has led to the entry of several new market players like Essential Medical, Inc. in the vascular closure devices market. The entry of these new players in a market where traditional pharma behemoths like Abbott Laboratories and Cardinal Health Inc. already exist is expected to lead to further innovation in the vascular closure devices market. Moreover, in order to further increase their clientele as well as increase their market share in the upcoming years, many of these market players have taken various strategic actions like partnerships and development of novel solutions which primarily focus on providing comfort to the patient, which is expected to keep the market competitive and constantly evolving.

Market Segmentation:

  • By Access
  • Femoral Access
  • Radial Access
  • By Type
  • Passive Vascular Closure Devices
  • Active Vascular Closure Devices
  • By End-Users
  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • By Procedure
  • Interventional Vascular Surgery
  • Interventional Cardiology
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Function
  • 4.4. Function Value Chain Analysis

5. Global Vascular Closure Devices (VCDs) Market Analysis, By Access

  • 5.1. Introduction
  • 5.2. Femoral Access
  • 5.3. Radial Access

6. Global Vascular Closure Devices (VCDs) Market Analysis, By Type

  • 6.1. Introduction
  • 6.2. Passive Vascular Closure Devices
  • 6.3. Active Vascular Closure Devices

7. Global Vascular Closure Devices (VCDs) Market Analysis, By End-Users

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Ambulatory Surgical Centers

8. Global Vascular Closure Devices (VCDs) Market Analysis, By Procedure

  • 8.1. Introduction
  • 8.2. Interventional Cardiology
  • 8.3. Interventional Radiology/Vascular Surgery

9. Global Vascular Closure Devices (VCDs) Market Analysis, By Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. UK
    • 9.4.2. Germany
    • 9.4.3. Italy
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Israel
    • 9.5.2. Saudi Arabia
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. Japan
    • 9.6.3. India
    • 9.6.4. Australia
    • 9.6.5. South Korea
    • 9.6.6. Taiwan
    • 9.6.7. Thailand
    • 9.6.8. Indonesia
    • 9.6.9. Others

10. Competitive Environment and Analysis

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. Company Profiles.

  • 11.1. Medtronic
  • 11.2. Terumo
  • 11.3. Abbott
  • 11.4. Cordis
  • 11.5. Biomerics
  • 11.6. Cardiva Medical, Inc.
  • 11.7. Vasorum Ltd
  • 11.8. Biotronik GMBH & CO.KG
  • 11.9. Boston Scientific Corporation
  • 11.10. TZ Medical, Inc